Viamet Pharmaceuticals' Financial Acquisition

Viamet Pharmaceuticals raised a round of funding on January 03, 2018. Investors include NovaQuest Capital Management.

Viamet Pharmaceuticals discovers and develops breakthrough therapies based on specialization in metalloenzyme chemistry and biology. The company's clinical portfolio includes novel agents to treat bot…

Articles about Viamet Pharmaceuticals' Financial Acquisition: